mrc

MRCT have recently launched a second collaboration with the University of Bristol in the area of pain medicine.

Substituted aminopyrimidine protein kinase B (PknB) inhibitors show activity against Mycobacterium tuberculosis

Researchers at the Breakthrough Breast Cancer Research Unit have used OPT imaging to measure changes in tumour volume.

Barbara Saxty has co-authored a Nature Communications paper entitled An intrinsically labile α-helix abutting the BCL9-binding site of β-catenin is required for its inhibition by carnosic acid.